HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The scid mouse as an experimental model for the evaluation of anti-Pneumocystis carinii therapy.

Abstract
The usefulness of scid mice bearing endogenous Pneumocystis carinii infection as a model for experimental chemotherapy was examined using standard compounds known to be effective against P. carinii. Trimethoprim/sulphamethoxazole was able to reduce pulmonary P. carinii cysts in a dose-dependent manner within the dose range studied (10/50 to 100/500 TMP/SMX mg/kg/d, bd, po, 5 days per week for 30 treatments). However, alterations in associated symptoms of infection (reduced body weight, increased lung weight, increased blood leucocytes and erythrocytes), was apparently not linearly dose-dependent. Blood and lung lavage fluid levels of sulphamethoxazole one hour post administration of trimethoprim/sulphamethoxazole was dose-dependent, but not linear with dose, and was apparently correlated to cyst reduction; trimethoprim was below the limit of detection at this time. Treatment of mice with 100/500 mg/kg/day trimethoprim/sulphamethoxazole required 2 weeks (bd for 10 days of treatment) before changes in indices of infection became significant. Pentamidine (20 mg/kg, sc, three times per week for 3 weeks) was nearly as effective as high-dose trimethoprim/sulphamethoxazole in reducing cysts, whereas lower doses were ineffective. Despite being unable to reduce pulmonary P. carinii infection, even low doses of pentamidine (6 or 2 mg/kg, sc, three times per week for 3 weeks) were able to reduce lung weights and blood leucocyte levels. This model of pulmonary P. carinii infections is amenable to chemotherapeutic intervention in an apparently dose-dependent fashion, and can be used to evaluate the capacity of compounds to eradicate P. carinii and resolve signs of infection.
AuthorsS Kunz, U Junker, J Blaser, B Joos, B Meyer, O Zak, T O'Reilly
JournalThe Journal of antimicrobial chemotherapy (J Antimicrob Chemother) Vol. 36 Issue 1 Pg. 137-55 (Jul 1995) ISSN: 0305-7453 [Print] England
PMID8537261 (Publication Type: Journal Article)
Chemical References
  • Anti-Infective Agents
  • Antifungal Agents
  • Pentamidine
  • Trimethoprim, Sulfamethoxazole Drug Combination
Topics
  • Animals
  • Anti-Infective Agents (therapeutic use)
  • Antifungal Agents (therapeutic use)
  • Blood Cell Count
  • Body Fluids (metabolism)
  • Dose-Response Relationship, Drug
  • Lung (microbiology)
  • Mice
  • Mice, SCID (microbiology)
  • Organ Size (drug effects)
  • Pentamidine (therapeutic use)
  • Pneumonia, Pneumocystis (blood, drug therapy, microbiology)
  • Trimethoprim, Sulfamethoxazole Drug Combination (pharmacokinetics, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: